GlassScriptPhysician profile
Justin Hawk
NPI 1154709830
$310.00
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $61.74 · 2023: $99.99 · 2024: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $83.81 | 2023-2024 | Monovisc |
| Stryker Corporation | $61.74 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $31.57 | 2024 | Iovera |
| Smith+Nephew, INC. | $30.60 | 2024 | Journey II, K-15 Pork |
| Djo, LLC | $28.98 | 2024 | Cmf |
| Vertex Pharmaceuticals Incorporated | $20.49 | 2024 | |
| Southern Edge Orthopaedics, INC. | $15.70 | 2023 | |
| Bioventus LLC | $15.08 | 2023 | Gelsyn-3 |
| Convatec INC. | $14.88 | 2023 | |
| Dynasplint Systems INC. | $7.15 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Hawk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.